Where can I find information about the standard of chemoradiotherapy for non small cell lung cancer

Updated on healthy 2024-05-01
2 answers
  1. Anonymous users2024-02-08

    In fact, we don't need to panic, it is not contagious. Next, I will introduce you to small cell lung cancer. Lung cancer is a serious disease that can lead to death.

    However, the symptoms of lung cancer can actually be subdivided, for example, non-small cell lung cancer is a classification of lung cancer, and this disease mainly occurs in the elderly, non-small cell lung cancer can have different periods, and there will be different lung cancer ** measures in different periods. Early. If the patient can be detected at an early stage, it is extremely beneficial.

    For elderly patients, there is no significant difference in the effect of cisplatin-based adjuvant chemotherapy with that of younger patients, and its compatibility drugs are the same as those of young patients. Locally advanced. Locally advanced refers to the patient's lung cancer has reached an advanced stage, but the site of occurrence is in the local part of the body.

    Randomized trials have shown that concurrent or sequential chemoradiotherapy has advantages over radiotherapy alone, but the dose and number of chemoradiotherapy cycles should be reduced and the timing adjusted on a case-by-case basis. Trials have confirmed that it is more feasible to reduce the dose of chemotherapy drugs or combine chemotherapy with cisplatin-free chemotherapy in combination with radiotherapy in older patients, but there is no uniform standard for specific adjustment methods.

    Phase 1 clinical trial results showed that single-agent chemotherapy, platinum-based or non-platinum-based combination chemotherapy and targeted drugs** of third-generation chemotherapy drugs were all better than the best support** and were statistically significant. Although cisplatin-based chemotherapy is still the standard** regimen for advanced non-small cell lung cancer, it has not been demonstrated in prospective clinical studies that cisplatin-based chemotherapy is more effective in elderly patients. The above is a brief introduction to non-small cell lung cancer, which can be seen that no matter what type of lung cancer it is, it can be classified, and there should be different coping methods and strategies for different periods.

    Patients should be aware of what period they are in, and knowing their condition can help to dispel fears.

  2. Anonymous users2024-02-07

    Small cell lung cancer is highly malignant, and there is indeed no particularly good way to do it. Depending on what you said, there should be no surgery. It's the 5th chemotherapy treatment, I don't know how effective it is now?

    Is it PR or CR? Haven't had radiotherapy, have you? Radiation therapy should be added on a case-by-case basis.

    Is it a limited period or is it already extensive? Nowadays, lung cancer ** should not rely too much on traditional Chinese medicine, traditional Chinese medicine can only play an auxiliary role. If you can explain the condition in more detail, I can give you some more explanations.

Related questions
12 answers2024-05-01

At present, the commonly used drugs are gefitinib and erlotinib, and the lung cancer guidelines formulated by the Ministry of Health recommend gefitinib and erlotinib as the first-line for patients with advanced non-small cell lung cancer**, and it is recommended for patients with mutations to detect EGFR gene mutations. In addition, there are drugs that target tumor angiogenesis, such as bevacizumab, endostatin, etc.

12 answers2024-05-01

Hello, non-small cell lung cancer patients should choose different comprehensive modes according to the type and stage of pathology, follow the evidence-based medical basis, and choose different comprehensive modes under the guidance of doctors**, and the common methods at present include surgery, chemotherapy, radiotherapy, molecular targeted drugs**, traditional Chinese medicine** and local intervention**. Common chemotherapy drugs are cisplatin, carboplatin, gemcitabine, pemetrexed, and paclitaxel. If the EGFR gene is mutated, targeted drugs such as erlotinib and gefitinib can be selected. >>>More

10 answers2024-05-01

Small cell lung cancer is the fastest growing lung cancer cell type, and it is easy to spread and metastasize, but whether it can be the best can not only depend on the cell type, but also on the morning or late of detection, whether it can be operated, the patient's physique, mentality, economic conditions, etc. In short, the combination of traditional Chinese and Western medicine will definitely achieve the best results.

20 answers2024-05-01

The specific chemotherapy depends on the condition.

and physical condition. >>>More

9 answers2024-05-01

Lung cancer may metastasize to bone.

Chemotherapy and radiation can also cause this pain. >>>More